IQN Path is pleased to endorse this important international survey on cytology-based biomarker testing. Laboratories worldwide are invited to take part.
The survey, which is being led by dr. Irena Srebotnik Kirbis (Faculty of Medicine, University of Ljubljana) with the collaboration of UK NEQAS and GenQA, aims to capture current cytology processing practices. This information will be used to design a pilot External Quality Assessment (EQA) program. Participation will help advance harmonization and quality assurance in this important and rapidly evolving field.
Survey open until 1 February 2026